MYC and neuroblastoma: High-risk neuroblastomas lacking amplified MYCN harbor rearrangements of other MYC gene family members, TERT or alternative mechanisms of telomere lengthening (ALT) often associated with ATRX gene mutations, the latter subtype being incompatible with high MYCN or MYC expression6,7 (later referred to as MYC(N)).